[1]梅丽军,姚 筱,王西强,等.左西孟旦联合辅酶Q10治疗扩张型心肌病临床疗效研究[J].陕西医学杂志,2023,52(10):1404-1406.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.027]
　MEI Lijun,YAO Xiao,WANG Xiqiang,et al.Efficacy of levosimendan combined with coenzyme Q10 in patients with dilated cardiomyopathy[J].,2023,52(10):1404-1406.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.027]
点击复制

左西孟旦联合辅酶Q10治疗扩张型心肌病临床疗效研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1404-1406
栏目:
药物与临床
出版日期:
2023-10-05

文章信息/Info

Title:
Efficacy of levosimendan combined with coenzyme Q10 in patients with dilated cardiomyopathy
作者:
梅丽军1; 姚 筱2; 王西强3; 崔倩卫3; 祝 领3; 邢玉洁3
(1.陕西省人民医院心血管内一科,陕西 西安 710068; 2.成都市第三人民医院健康管理中心,四川 成都 610031; 3.陕西省人民医院医务处,陕西 西安 710068)
Author(s):
MEI Lijun; YAO Xiao; WANG Xiqiang; CUI Qianwei; ZHU Ling; XING Yujie
(Department of Cardiovascular Medicine,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
扩张型心肌病;  左西孟旦;  辅酶Q10;  心力衰竭;  心功能;  运动耐量
Keywords:
Dilated cardiomyopathy;  Levosimendan;  Coenzyme Q10;  Heart failure;  Cardiac function;  Exercise tolerance
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.027
文献标志码:
A
摘要:
目的:观察在扩张型心肌病患者中使用左西孟旦联合辅酶Q10后对患者运动耐量和心功能的疗效。方法:选取80例扩张型心肌病患者,随机分成试验组及对照组,每组40例,两组均要接受常规抗心衰药物治疗,试验组在此基础上使用左西孟旦联合辅酶Q10,疗程为1个月,观察两组治疗前后的血清N末端脑利钠肽前体(NT-proBNP)、心功能分级、6 min最大步行距离、心脏超声及药物不良反应。结果:试验组患者的6 min最大步行距离较对照组显著增加,NT-proBNP水平较对照组则显著降低,心功能较对照组明显上升,差异具有统计学意义(均P<0.05)。结论:扩张型心肌病患者使用左西孟旦联合辅酶Q10后可以使患者的心功能以及运动耐量提高,无明显的不良反应。
Abstract:
Objective:To observe the effects of levosimendan combined with coenzyme Q10 on cardiac function and exercise tolerance in patients with dilated cardiomyopathy.Methods:Randomly dividing 80 patients with dilated cardiomyopathy into experimental group and control group,each group has 40 cases in.Two groups received routine drug treatment for heart failure.On this basis,the experimental group received levosimendan combined with coenzyme Q10.The course of treatment is 1 month.The cardiac function grade,6-min maximum walking distance,cardiac ultrasound,plasma N terminal pro B type natriuretic peptide(NT-proBNP)and adverse drug reactions were observed and compared between the two groups before and after treatment.Results:In the experimental group,the 6-min maximum walking distance was significantly increased,the NT-proBNP level was significantly lower,and the cardiac function was significantly higher than that in the control group(all P<0.05).Conclusion:The use of levosimendan combined with coenzyme Q10 can improve cardiac function and exercise tolerance in patients with dilated cardiomyopathy without obvious adverse reactions.

参考文献/References:

[1] Lakdawala NK,Winterfield JR,Funke BH.Dilated cardiomyopathy[J].Circ Arrhythm Electrophysiol,2013,6(1):228-237.
[2] Mc-Nally EM,Mestroni L.Dilated cardiomyopathy:Genetic determinants and mechanisms[J].2017,121(7):731-748.
[3] Mathew T,Williams L,Navaratnam G,et al.Diagnosis and assessment of dilated cardiomyopathy:A guideline protocol from the british society of echocardiography [J].Echo Res Pract,2017,4(2):1-13.
[4] 李文波.左西孟坦对心力衰竭急性加重期患者心功能及QOL评分的影响[J].药品评价,2020,17(4):32-34.
[5] Radosevich M,Couture EJ,Nabzdyk C.Levosimendan and septic cardiomyopathy:A key that may have found its lock?[J].J Cardiothorac Vasc Anesth,2023,37(3):350-352.
[6] 吴昊晟,汤日波.扩张型心肌病合并左心室血栓的研究进展[J].心肺血管病杂志,2023,42(1):84-87.
[7] Dal-Ferro M,Stolfo D,Altinier A,et al.Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy[J].Heart,2017,103(21):1704-1710.
[8] Weintraub RG,Semsarian C,Macdonald P.Dilated cardiomyopathy[J].Lancet,2017,390(10092):400-414.
[9] 柴松波,王振涛,刘舜禹.抗纤益心方治疗扩张型心肌病气虚血瘀证队列研究[J].陕西中医.2019,40(1):49-51.
[10] Kapoor MC.Levosimendan in right ventricular dysfunction[J].Ann Card Anaesth,2023,26(1):1-3.
[11] Abbate A,Van-Tassell BW.Levosimendan in advanced heart failure:Where do we stand? [J].J Cardiovasc Pharmacol,2018,71(3):127-128.
[12] 余星燕,冯金华,邢 坤.左西孟旦与心力衰竭研究进展[J].陕西医学杂志,2014,43(1):112-114.
[13] Gecit I,Kavak S,Ytiksel M B,et al.Effect of short-term treatment with levo simendan on oxidative stress in renal tissues of rats[J].Toxicol Ind Health,2014,30(1):47-51.
[14] 朱子雄,李学文.左西孟旦治疗心力衰竭研究进展[J].中西医结合心脑血管病杂志,2023,21(5):863-865.
[15] Kocharian A,Shabanian R,Rafiei-Khorgami M,et al.Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy[J].Cardiol Young,2009,19(5):501-506.
[16] Enright PL,Sherrill DL.Reference equations for the six-minute walk in healthy adults[J].Am J Respir Crit Care Med,1998,158(5):1384-1387.
[17] Salah K,Stienen S,Pinto YM,et al.Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction[J].Heart,2019,105(15):1182-1189.
[18] Cao Z,Jia Y,Zhu B.BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine[J].Int J Mol Sci,2019,20(8):1820.
[19] 申文文,延欢欢.不同类型慢性心力衰竭患者血清肌钙蛋白T和N末端B型钠尿肽原水平变化及临床意义[J].陕西医学杂志,2021,50(9):1109-1113.
[20] 任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者 NT-proBNP、hs-CRP、VEGF的影响[J].陕西中医,2019,40(6):711-713.

相似文献/References:

[1]李 刚,陈紫凡△.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.032]
　LI Gang,CHEN Zifan..Curative effect of levosimendan in treatment of elderly patients with chronic heart failure and its influence on cardiac function and renin-angiotensin-aldosterone system[J].,2020,49(10):1321.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.032]
[2]高泽林,李晓妮.新活素与左西孟旦治疗缺血性心肌病致心力衰竭疗效及对患者心功能指标的影响[J].陕西医学杂志,2024,(10):1394.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.021]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年基金资助项目(81700401); 陕西省卫生健康科研项目(2022B004); 中国博士后科学基金资助面上项目(2022M722576); 陕西省人民医院科技人才支持计划项目(2021JY-18)
更新日期/Last Update: 2023-10-07